Significance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patients-Reference-Cited by-同舟云学术

Significance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patients

Published:2013-03-28 Issue:13 Volume:121 Page:2424-2431
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Walter Roland B.¹²³,Othus Megan⁴,Burnett Alan K.⁵,Löwenberg Bob⁶,Kantarjian Hagop M.⁷,Ossenkoppele Gert J.⁸,Hills Robert K.⁵,van Montfort Kees G. M.⁹,Ravandi Farhad⁷,Evans Anna⁵,Pierce Sherry R.⁷,Appelbaum Frederick R.¹¹⁰,Estey Elihu H.¹²

Affiliation:

1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

2. Division of Hematology, Department of Medicine, and

3. Department of Epidemiology, University of Washington, Seattle, WA;

4. Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA;

5. Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom;

6. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands;

7. Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX;

8. Division of Hematology, VU University Medical Center, Amsterdam, The Netherlands;

9. Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands; and

10. Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA

Abstract

Key Points The FAB type (ie, M0-M7) does not provide prognostic information for cases of “AML, NOS” in the 2008 WHO classification.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/13/2424/1364743/2424.pdf

Reference14 articles.

1. Acute myeloid leukemia.;Löwenberg;N Engl J Med,1999

2. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.;Döhner;Blood,2010

3. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.;Bennett;Br J Haematol,1976

4. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.;Bennett;Ann Intern Med,1985

5. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group.;Bennett;Ann Intern Med,1985

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cellular hierarchy of acute myeloid leukemia informs personalized treatment;2024-07-24

2. Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies;International Journal of Molecular Sciences;2024-06-08

3. Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated factors in the country’s tertiary referral hospital, Ethiopia;BMC Cancer;2024-05-24

4. Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations;International Journal of Molecular Sciences;2024-05-07

5. Molecular landscape of the interleukin-40 encoding gene, C17orf99, in patients with acute myeloid leukemia;Gene;2024-04